Portuguese Digital Health Firm Hope Care Raises $7.1M to Scale Remote Monitoring

Jan de Vries · 2026-09-08

Let's talk about something that could genuinely change how chronic disease is managed across Europe. A Portuguese digital health company called Hope Care has just closed a Series A funding round of €6 million (roughly $7.1 million), and honestly, the implications here are pretty exciting for anyone following healthcare innovation. This isn't just another startup raising money to burn through. Hope Care has been at this for over a decade, building a regulated platform that actually works inside public health systems. That's a big deal because getting regulatory approval and integrating with existing healthcare infrastructure is notoriously difficult. ### Who's Backing Hope Care and Why It Matters The round was led by Iberis Capital, a Portuguese private equity firm, with participation from Vieira de Matos – VDM Capital and existing shareholder Buenavista Equity Partners. When existing investors double down, that's usually a strong signal they believe in the company's trajectory. João Henriques, Partner at Iberis Capital, put it well: "Across Europe, health systems are straining under the weight of chronic disease, still responding to crises rather than preventing them. Hope Care is one of the few companies that pairs proven clinical evidence with the regulatory maturity to operate inside public health systems at scale." ### The Technology Behind the Hype Founded in 2012, Hope Care developed OpMA, a platform that powers centralized remote care and telehealth centers. Think of it as a command center for chronic care management. It brings together data from medical devices, patient-reported outcomes, and clinical workflows into one unified environment. What does that actually mean in practice? Healthcare organizations can design, deploy, and scale digital care programs across multiple chronic conditions. Instead of reacting to health crises when they happen, care teams can intervene proactively. That shift from reactive to proactive care is where the real value lies. ### Real Results, Not Just Promises Hope Care isn't just making claims; they have data to back it up. In a 12-month analysis involving 43 patients with chronic obstructive pulmonary disease (COPD), their program was associated with a 76% reduction in hospital days and a 74% reduction in emergency department visits. That translates to estimated annual savings of about $5,300 per patient. Here's what that means in human terms: - Fewer hospital stays means patients spend more time at home with their families - Less strain on emergency departments means faster care for everyone - Lower costs per patient free up resources for other critical healthcare needs ### Expanding Across Europe Hope Care isn't staying put. They're already running remote patient monitoring programs in Portugal and France, including a partnership with GHT Saône-et-Loire Bresse Morvan. Switzerland is also on the docket with a project in the works. Germany is where things get interesting. The company has established Hope Care GmbH, headquartered at Medical Valley in Erlangen, with the first deployment scheduled for October 2026. Romania is also in the pipeline, with local setup activities beginning by the end of September 2026. In Portugal alone, Hope Care's technology is already used by 15 Local Health Units, covering roughly 45% of all registered users in the national health service. They're also active with regional health services in Madeira and the Azores, plus private providers, social care organizations, and municipalities. ### What This Funding Means for the Future José Paulo Carvalho, founder and CEO of Hope Care, sees this as a turning point. "After more than a decade working with healthcare institutions, we have built a regulated platform that delivers measurable outcomes for patients, healthcare professionals and healthcare systems." The company plans to use the capital to accelerate its European expansion, strengthen commercial and operational capabilities, and speed up deployment of remote monitoring programs in key markets. And the momentum is real—first-half sales in 2026 reached 2.5 times the level from the same period in 2025. This story is worth watching. As healthcare systems everywhere struggle with aging populations and rising chronic disease rates, solutions like Hope Care's could become essential infrastructure rather than optional extras. The fact that they've proven their model in one country and are now scaling across borders suggests we might be seeing the early stages of something significant in digital health.